NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes
- 31 March 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 45 (2) , 157-163
- https://doi.org/10.1016/s0939-6411(97)00107-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gd(III) complexes as contrast agents for magnetic resonance imaging: a proton relaxation enhancement study of the interaction with human serum albuminJBIC Journal of Biological Inorganic Chemistry, 1996
- Molecular Recognition of R- and T-States of Human Adult Hemoglobin by a Paramagnetic Gd(III) Complex by Means of the Measurement of Solvent Water Proton Relaxation RateJournal of the American Chemical Society, 1995
- Paramagnetic Polymerized Liposomes: Synthesis, Characterization, and Applications for Magnetic Resonance ImagingJournal of the American Chemical Society, 1995
- Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agentsMagnetic Resonance in Medicine, 1994
- Synthesis and NMRD studies of gadolinium(3+) complexes of macrocyclic polyamino polycarboxylic ligands bearing .beta.-benzyloxy-.alpha.-propionic residuesInorganic Chemistry, 1992
- Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ionsMagnetic Resonance in Medicine, 1992
- Gd-DOTA Loaded into Red Blood Cells, a New Magnetic Resonance Imaging Contrast Agents for Vascular SystemPublished by Springer Nature ,1992
- Rationale and applications for macromolecular Gd‐based contrast agentsMagnetic Resonance in Medicine, 1991
- Peroral administration of nanoparticlesAdvanced Drug Delivery Reviews, 1991
- Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liverMagnetic Resonance in Medicine, 1991